Adams R Mark's Form 4 filing
Adaptive Biotechnologies Corp (ADPT) · filed Jan 11, 2023
- Accession no.
- 0001209191-23-003052
- Filed
- Jan 11, 2023
- Trade date
- Jan 9-10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $26.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Adams R MarkCIK 0001808905 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | Common Stock | SSaleDisposed | −995 | $8.50 | −$8,457.5 | 115,648 | Direct | |
| Jan 10, 2023 | Common Stock | SSaleDisposed | −2,130 | $8.58 | −$18,275.4 | 113,518 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.